News

  • Glaucoma grant award £60,000

    The IGA and UKEGS are pleased to invite applications up to £60,000 to fund high quality research that enhances the detection and treatment of glaucoma in order to improve the quality of life for patients.

    We will consider applications for clinical and laboratory-based research projects into the causes and prevention, early detection, diagnosis, treatment or improving the quality of life of people of all ages living with glaucoma and allied conditions.

    Lead researchers must be based in the UK or Eire.

    Applications can be downloaded here

    Closing date: 18 October 2019

    Grants will be awarded on the basis of:

    • scientific content
    • likelihood of a conclusive outcome of the proposed study
    • likely impact of the research on patient care or appropriate scientific advance or understanding of glaucoma
    • location in a suitable institution
    • presentation
    • value for money
    • ethical considerations

    Full terms of awards are set out in the IGA Terms and Conditions of grant funding.

     

    Read more

  • Do you use Moorfields Eye Hospital?

    Then you may want to have your say in plans to move the hospital from its current site…..

    If you came along to our AGM back in March you may have heard the IGA Professor of Glaucoma, Ted Garway-Heath talk about plans to relocate Moorfields. The world famous eye hospital is proposing to build a new centre on the site of St Pancras Hospital, just north of King’s Cross and St Pancras stations in central London. Services would move to the new centre from the current hospital facilities on City Road in Islington, along with Moorfields’ partner, the UCL Institute of Ophthalmology. If the move goes ahead, Moorfields and UCL would sell their current land on City Road and all proceeds of the sale would be reinvested in the new centre.

    A public consultation is being held, and if you would like to find out more about the plans and make your views knows, please go to https://oriel-london.org.uk/public-consultation/proposed-move-and-options/ by 16 September 2019.

    Read more

  • New Cardiff Visual Impairment Social Group- coming August 2019

    On Thursday 15 August at Llanishen Hub (CARDIFF) a new social group for those living with a visual impairment will be starting from 12 - 2pm.

    If you would like more information or If you would like to come along/know of anyone who may be interested then please contact Sue Baskerville: SBaskerville@caerdydd.gov.uk / SBaskerville@cardiff.gov.uk

    Read more

  • Interventional Procedures Programme: Non invasive focused ultrasound for the treatment of glaucoma

    NICE is carrying out a project on the procedure 'Non invasive focused ultrasound for the treatment of glaucoma'. We are looking at how well the procedure is working and if it is safe enough to be used more widely in the NHS in the future.

    To take part in the survey click here.

    The survey should take no more than 10 minutes to complete.

    If you would like to find out more about NICE of the programme, please visit the website. For assistance or advice on completing this questionnaire, please email pip@nice.org.uk or call 0161 870 3020.

    Read more

  • Congratulations to Professor David (Ted) Garway-Heath

    We are delighted to announce that Professor David (Ted) Garway-Heath, IGA Professor of Ophthalmology for Glaucoma and Allied Studies, has been voted Top Mentor worldwide in the 2019 'power list' from the Ophthalmologist: https://theophthalmologist.com/power-list/2019

    Click on the image to read his short interview.

    Congratulations from all of us at the IGA!

    Read more

  • The International Glaucoma Association (IGA) and Santen Produce Unique ‘Eye Test’ for World Glaucoma Week

    The International Glaucoma Association (IGA) and specialist ophthalmology company Santen Pharmaceutical Co Ltd, have joined forces to produce a unique interactive ‘eye test’ to demonstrate what the world looks like to people living with glaucoma. The test is part of a joint campaign to raise awareness of the eye condition among younger first-degree relatives of older people most likely to develop glaucoma.

    The test will be posted on IGA and Santen social channels (Facebook, Twitter and LinkedIn) and on their respective websites in time for World Glaucoma Week, 10-16 March 2019. The quiz consists of a series of intriguing questions where images are shown that simulate missing objects and cloudy vision which are the hallmark of glaucoma, and leads to more information about glaucoma.
    It is estimated that there are 700,000 people with glaucoma in the UK today, but half are undiagnosed. If left untreated glaucoma can lead to serious loss of vision, with up to 40 per cent of sight being permanently lost before the effects are noticed by the individual. Once sight is lost it cannot be recovered. Glaucoma is the most common cause of preventable blindness. Many people are unaware that glaucoma has no symptoms in the early stages, so regular eye health checks (every two years, or every 1-2 years for over 40s, especially where there is a family history of glaucoma) are really important to detect the condition. Early diagnosis and regular treatment, usually with eye drops, can preserve vision and enable people to carry on with their lives.
    Commenting on the initiative, Karen Osborn, CEO of the IGA says: “We’re delighted to be partnering with Santen in creating this unique quiz to raise awareness of glaucoma among a younger audience. By reaching people via their social channels in a visually impactful way, we hope to create a lasting impression of what glaucoma sight loss looks like, so they can be aware of early symptoms among older relatives and can encourage regular eye checks to pick up the condition early.”

    Paul Campbell, Marketing Manager at Santen says, “As a global pharmaceutical company dedicated to ophthalmology, Santen is committed to the protection of eyesight and the health of patients. We are proud to be partnering with the International Glaucoma Association on this awareness-raising initiative. Glaucoma can result in sight loss if it isn’t diagnosed and treated early and consistently, so this interactive ‘eye test’ is an innovative way to engage and educate people on the importance of regular eye checks and the potential impact of the disease.”

    -ENDS-
    For further information please contact Richenda Kew or Tracey Fabre on: 01233 64 81 6, email: marketing@iga.org.uk or Annabel Hillary, 07884 430862, annabel@prwhenyouneedit.co.uk
    or Mary-Jane Greenhalgh, 07866 722051, maryjane@prwhenyouneedit.co.uk

    About the International Glaucoma Association

    1. The International Glaucoma Association (IGA) is the charity for people with glaucoma. Its mission is to raise awareness of glaucoma, promote research related to early diagnosis and treatment, and to provide support to patients and all those who care for them. For more information, please visit: www.glaucoma-association.com

    2. Set up in 1974, it is the oldest patient based glaucoma association in the world and it is a registered charity in England and Wales, and also in Scotland.

    3. As part of its support services, the IGA operates the Sightline (telephone helpline) and provides free information on any aspect of glaucoma.

    4. For more information about glaucoma, contact the International Glaucoma Association (IGA) telephone helpline on 01233 64 81 70 (Monday to Friday, 9.30am–5.00pm)

    5. In England, Wales and Northern Ireland, close relatives of people with glaucoma who are aged 40 plus can have a sight test and examination by an optometrist which is paid for by the NHS, and everyone aged 60 and over is entitled to free testing. In Scotland, the NHS will pay for glaucoma examinations offered by optometrists, regardless of age.

    About Santen
    As a specialised company dedicated to the ophthalmology field, Santen carries out research, development, marketing, and sales of pharmaceuticals, over-the-counter products and devices. Santen has long been the market leader in Japan for prescription ophthalmic pharmaceuticals and is now a leader in the sector in the EMEA (Europe, Middle East and Africa) region. With scientific knowledge and organizational capabilities nurtured over nearly 130 years, Santen products and services now reach over 60 countries, contributing to the well-being of patients, their loved ones and consequently to society. For more information, please visit Santen websites www.santen.com (Japan headquarters) and www.santen.eu (EMEA).

    Read more

  • Ramadan and Eye Drops

    Did you see our campaign last year on Eye Drops and Ramadan? Did it change how you instil your drops, during Ramadan or afterwards?

    If so we would love to hear from you, to support our campaign for this year.

    We want to help more Muslims across the UK protect their sight by understanding how and why to take drops during the holy month, and we need you to help us!

    Please contact j.bradley@iga.org.uk for more information.

    Read more

  • UK and Éire Glaucoma Society

    We are delighted to announce that abstract submission and registration for the 2019 conference are now open. The UKÉGS is due to be held on 21st and 22nd November 2019 at Glasgow Science Centre. For further information, or to register your attendance, please click here.

    Read more

  • NICE quality standards

    The IGA is supporting the new NICE quality standards for serious eye disorders, covering the diagnosis and management of glaucoma and other eye conditions. Read the full standard here https://www.nice.org.uk/guidance/qs180

    Read more

  • DVLA Medical Panel Lay Members: recruitment

    Are you passionate about driving and road safety? Do you have an interest in medical conditions and their impact on safe driving? Maybe you’ve got experience as a carer or doing voluntary work? If you do, then the DVLA would love to hear from you!

    The DVLA are currently recruiting for lay members for their medical panels, including those for visual disorders. For more information, please visit the Civil Service Jobs website.

    Recruitment closes on 3 February 2019

    Read more

1-10 of 99

Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. ...
  7. 10